Galderma Group AG
GALD
Peringkat dalam Saham
#459
Galderma Group AG operates as a dermatology company worldwide. The company... Galderma Group AG operates as a dermatology company worldwide. The company delivers a science-based portfolio of brands and services for the dermatology market, including injectable aesthetics, dermatological skincare, and therapeutic dermatology. Its portfolio of flagship brands includes Azzalure, ALLUZIENCE, Dysport, Restylane, Restylane Skinboosters, Sculptra, Cetaphil, ALASTIN, Soolantra, Epiduo, Epiduo Forte, Differin, AKLIEF, Oracea, Metvix, NEMLUVIO, Relfydess, Benzac, and Loceryl in therapeutic dermatology. The company was founded in 1981 and is headquartered in Zug, Switzerland.
Harga Saham
$224.81
Kapitalisasi Pasar
$52.42B
Perubahan (1 hari)
6.31%
Perubahan (1 tahun)
31.28%
Negara
CH
Perdagangan Galderma Group AG (GALD)
Kategori
Healthcare
Riwayat dividen untuk Galderma Group AG (GALD)
Saham Galderma Group AG (simbol: GALD) telah membayar total 2 dividen.
Total semua dividen (disesuaikan dengan stock split): $0.50
Imbal hasil dividen (TTM): 0.0019
Total semua dividen (disesuaikan dengan stock split): $0.50
Imbal hasil dividen (TTM): 0.0019
Pembayaran dividen untuk Galderma Group AG (GALD) dari 2025 hingga 2026
Pembayaran dividen tahunan
| Tahun | Dividen (disesuaikan dengan stock split) | Mengubah |
|---|---|---|
| 2026 (TTM) | $0.35 | 133.33% |
| 2025 | $0.15 | 0.00% |
Daftar semua pembayaran dividen
| Tahun | Dividen | Mengubah |
|---|---|---|
| 2026 (TTM) | $0.35 | 133.33% |
| 2025 | $0.15 | 0.00% |
Pembayaran dividen untuk perusahaan sejenis atau pesaing
| Perusahaan | Jumlah pembayaran dividen | Negara |
|---|---|---|
| 13.00% |
DE
|
|
| 26.00% |
DE
|
|
| 55.00% |
JP
|
|
| 39.00% |
IN
|
|
| 26.00% |
CN
|
